Trial Profile
Phase II study of VR647 for Asthma in children
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Sep 2018
Price :
$35
*
At a glance
- Drugs Budesonide (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 11 Sep 2018 According to a Vectura media release, data expeted in H1 2018.
- 21 Mar 2018 According to a Vectura media release, the study is expected to be complete in Q3 2018.
- 04 Jan 2018 According to a Vectura media release, first patient has been dosed in December 2017 and activities are expected to complete in mid-2018.